Identification of potential sepsis therapeutic drugs using a zebrafish rapid screening approach
Mark W. Widder, Chance M Carbaugh, William H. van der Schalie, Ronald Miller, Linda M. Brennan, Ashley Moore, Robert F. Campbell, Kevin S. Akers, Roseanne A. Ressner, Mónica Miró Martín, Michael S. Madejczyk, Blair C. R. Dancy, Patricia J. Lee, Charlotte Anne Lanteri
This study identifies three FDA-approved drugs that rescue zebrafish from sepsis-like endotoxicity with no neurobehavioral side effects.
Life · Dec 20, 2024Peer-reviewedPharmacology & Toxicology